James B Rottman

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Roux En Y Gastric Bypass

Genome Wide Association

Combination Therapy

Immune Response

Top Venues

Science translational medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Olmo Sonzogni, Daniel E Zak, Maria Stella Sasso, Rochelle Lear, Alice Muntzer, Manuela Zonca, Katy West, Brian R Champion, James B Rottman
T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice. Oncoimmunology 11 (1) (2022)
Samuel J Klempner, Johanna C Bendell, Victoria Meucci Villaflor, Laura LaNiel Tenner, Stacey M Stein, James B Rottman, Girish S Naik, Cynthia A Sirard, Michael H Kagey, Marya F Chaney, John H Strickler
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers. Molecular cancer therapeutics 20 (11) (2021)
Elizabeth A Killion, Jinghong Wang, Junming Yie, Stone D-H Shi, Darren Bates, Xiaoshan Min, Renee Komorowski, Todd Hager, Liying Deng, Larissa Atangan, Shu-Chen Lu, Robert J M Kurzeja, Glenn Sivits, Joanne Lin, Qing Chen, Zhulun Wang, Stephen A Thibault, Christina M Abbott, Tina Meng, Brandon Clavette, Christopher M Murawsky, Ian N Foltz, James B Rottman, Clarence Hale, Murielle M Véniant, David J Lloyd
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models. Science translational medicine 10 (472) (2019)